The Effects of Nicotine on Cortical Excitability After Exercise A Double-Blind Randomized, Placebo-controlled, Crossover Study

被引:4
|
作者
Zandonai, Thomas [1 ,2 ]
Pizzolato, Fabio [3 ]
Tam, Enrico [3 ]
Bruseghini, Paolo [4 ]
Chiamulera, Cristiano [5 ]
Cesari, Paola [3 ]
机构
[1] Miguel Hernandez Univ, Dept Pharmacol Pediat & Organ Chem, Elche, Spain
[2] Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Dept Expt Psychol, Fac Psychol, Granada, Spain
[3] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy
[4] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy
[5] Univ Verona, Dept Diagnost & Publ Hlth, Neuropsychopharmacol Lab, Verona, Italy
关键词
nicotine; smokeless tobacco; cortical excitability; exercise; TMS; CORTICOMOTOR EXCITABILITY; POSTEXERCISE DEPRESSION; PERFORMANCE; POTENTIALS;
D O I
10.1097/JCP.0000000000001246
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose The use of smokeless tobacco/nicotine products is common among athletes, but clear evidence for their positive or negative effect on sports performance is lacking. Nicotine is a psychoactive substance involved in numerous neuronal processes including cortical excitability. The aim of this study was to evaluate its effect on cortical excitability associated with aerobic exercise in nicotine-naive healthy volunteers. Methods Ten nicotine-naive healthy volunteers were recruited for this double-blind, randomized, crossover study to compare the effect of snus (8 mg nicotine), an oral, smokeless tobacco product, to placebo on cortical excitability before and after aerobic exercise. Transcranial magnetic stimulation (TMS) was used to measure changes in corticomotor excitability (motor-evoked potentials, MEPs) and electromyography of leg muscles during maximal voluntary contractions (MVC) to assess changes in muscle contractions. Before and after aerobic exercise and with or without nicotine treatment, MEPs and MVCs were measured. Results Analysis of TMS data showed lower motor cortex activation (lower MEP amplitude) after snus administration compared with placebo, whereas electromyography data showed no difference in muscle contraction between snus and placebo treatment. Conclusions These findings suggest a general reduction in cortical excitability, without no relevant effect on physical performance.
引用
收藏
页码:495 / 498
页数:4
相关论文
共 50 条
  • [1] Effects of Mexiletine and Lacosamide on Nerve Excitability in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Ruijs, Titia Q.
    Koopmans, Ingrid W.
    de Kam, Marieke L.
    van Esdonk, Michiel J.
    Koltzenburg, Martin
    Groeneveld, Geert Jan
    Heuberger, Jules A. A. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (05) : 1008 - 1019
  • [2] Transdermal nicotine in PD - A randomized, double-blind, placebo-controlled study
    Vieregge, A
    Sieberer, M
    Jacobs, H
    Hagenah, JM
    Vieregge, P
    NEUROLOGY, 2001, 57 (06) : 1032 - 1035
  • [3] Transdermal nicotine in PD: A randomized, double-blind, placebo-controlled study
    Allam, MF
    NEUROLOGY, 2002, 58 (07) : 1133 - 1133
  • [4] BounceBack™ capsules for reduction of DOMS after eccentric exercise: a randomized, double-blind, placebo-controlled, crossover pilot study
    Udani, Jay K.
    Singh, Betsy B.
    Singh, Vijay J.
    Sandoval, Elizabeth
    JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION, 2009, 6
  • [5] A randomized, double-blind, placebo-controlled crossover study on oral ATP administration
    Coolen, Erik
    Arts, Ilja
    Bours, Martijn
    Huyghebaert, Nathalie
    Cohen, Stuart Martien
    Bast, Aalt
    Dagnelie, Pieter
    PURINERGIC SIGNALLING, 2008, 4 : S196 - S197
  • [6] Octreotide in hepatorenal syndrome: A randomized, double-blind, placebo-controlled, crossover study
    Pomier-Layrargues, G
    Paquin, SC
    Hassoun, Z
    Lafortune, M
    Tran, A
    HEPATOLOGY, 2003, 38 (01) : 238 - 243
  • [7] Randomized, double-blind, placebo-controlled crossover study of donepezil in Down syndrome
    Kishnani, PS
    Spiridigliozzi, GA
    Heller, JH
    Sullivan, JA
    Crissman, BG
    Hauser, E
    Grambow, SC
    Doraiswamy, PM
    Krishnan, RR
    NEUROLOGY, 2005, 64 (06) : A106 - A106
  • [8] Estradiol in premenstrual asthma: A double-blind, randomized, placebo-controlled, crossover study
    Ensom, MHH
    Chong, G
    Zhou, DY
    Beaudin, B
    Shalansky, S
    Bai, TR
    PHARMACOTHERAPY, 2003, 23 (05): : 561 - 571
  • [9] Effects of SuperUlam on Supporting Concentration and Mood: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
    Udani, Jay K.
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [10] Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects
    Becker, Anna M.
    Holze, Friederike
    Grandinetti, Tanja
    Klaiber, Aaron
    Toedtli, Vanja E.
    Kolaczynska, Karolina E.
    Duthaler, Urs
    Varghese, Nimmy
    Eckert, Anne
    Grunblatt, Edna
    Liechti, Matthias E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (04) : 886 - 895